Zhejiang Shengda Bio-Pharm Co (SHSE:603079) ROCE %: 3.80% (As of Mar. 2026)


SHSE:603079 Zhejiang Shengda Bio-Pharm Co Ltd SHSE:603079
61 GF Score
Price ¥11.18
GF Value ¥14.37
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Zhejiang Shengda Bio-Pharm Co ROCE %?

Zhejiang Shengda Bio-Pharm Co SHSE:603079 -1.67% 61 ROCE % is 3.80% as of Mar. 2026. GuruFocus rates SHSE:603079 with a GF Score™ of 61/100 and a GF Value™ of ¥14.37 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhejiang Shengda Bio-Pharm Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 3.80%.

Zhejiang Shengda Bio-Pharm Co  (SHSE:603079) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhejiang Shengda Bio-Pharm Co ROCE % Related Terms

Zhejiang Shengda Bio-Pharm Co ROCE % Historical Data

* Premium members only.

The historical data trend for Zhejiang Shengda Bio-Pharm Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Shengda Bio-Pharm Co ROCE % Chart

Zhejiang Shengda Bio-Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.37 3.03 -3.14 3.46 4.65

Zhejiang Shengda Bio-Pharm Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.19 5.23 4.67 1.66 3.80
SHSE:603079
61GF Score
Zhejiang Shengda Bio-Pharm Co Ltd SHSE:603079
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Shengda Bio-Pharm Co ROCE % Calculation

Zhejiang Shengda Bio-Pharm Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=81.036/( ( (1785.311 - 251.384) + (2198.55 - 246.7) )/ 2 )
=81.036/( (1533.927+1951.85)/ 2 )
=81.036/1742.8885
=4.65 %

Zhejiang Shengda Bio-Pharm Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=74.792/( ( (2198.55 - 246.7) + (2192.515 - 210.467) )/ 2 )
=74.792/( ( 1951.85 + 1982.048 )/ 2 )
=74.792/1966.949
=3.80 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.80% mean?
Zhejiang Shengda Bio-Pharm Co (SHSE:603079) has a ROCE % of 3.80% as of Mar. 2026.
Is Zhejiang Shengda Bio-Pharm Co's ROCE % too high?
Zhejiang Shengda Bio-Pharm Co's current ROCE % is 3.80%. The Drug Manufacturers industry median ROCE % is 7.03. Zhejiang Shengda Bio-Pharm Co's value of 3.80% is 45.9% below this industry median. Overall, Zhejiang Shengda Bio-Pharm Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Shengda Bio-Pharm Co's ROCE % compare to ZTS and UTHR?
Zhejiang Shengda Bio-Pharm Co's ROCE % of 3.80% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Zhejiang Shengda Bio-Pharm Co's value of 3.80% is 45.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Shengda Bio-Pharm Co's current ROCE % of 3.80% is 45.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Shengda Bio-Pharm Co's current ROCE % is 3.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Shengda Bio-Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Shengda Bio-Pharm Co (SHSE:603079) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.37, compared to a current price of ¥11.18 — trading 22.2% below its estimated fair value. The current ROCE % is 3.80% and 45.9% below the Drug Manufacturers industry median of 7.03. Zhejiang Shengda Bio-Pharm Co's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Zhejiang Shengda Bio-Pharm Co (SHSE:603079), the current ROCE % is 3.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Shengda Bio-Pharm Co stock appears to be undervalued. The current stock price of ¥11.18 is trading 22.2% below its estimated GF Value™ of ¥14.37. GuruFocus considers Zhejiang Shengda Bio-Pharm Co to be Modestly Undervalued.

Key valuation signals for SHSE:603079:

  • ROCE %: 3.80%
  • GF Value™: ¥14.37 vs. price of ¥11.18 (22.2% below fair value)
  • GF Score™: 61/100 with 5 warning signs
  • Industry Position: 45.9% below the Drug Manufacturers median

No single metric tells the full story. See the SHSE:603079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Shengda Bio-Pharm Co Business Description

Address No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid, and other vitamin products, nisin, natamycin, and sucrose fermentation products.
61GF Score

Get the complete analysis for SHSE:603079

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥11.18
Price
¥14.37
GF Value